| # | Drug | Count |
|---|---|---|
| 0 | LENVATINIB | 39 |
| 1 | BEVACIZUMAB | 30 |
| 2 | CARBOPLATIN | 24 |
| 3 | PACLITAXEL | 16 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 16 |
| 5 | CYCLOPHOSPHAMIDE | 15 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| 8 | DOXORUBICIN | 15 |
| 9 | DOCETAXEL | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 3 | 0.0067 |
| 1 | TISLELIZUMAB-JSGR | 1 | 0.0045 |
| 2 | PANTHENOL | 1 | 0.0034 |
| 3 | PORFIMER SODIUM | 1 | 0.0029 |
| 4 | CRIZANLIZUMAB | 2 | 0.0014 |
| 5 | LENVATINIB | 39 | 0.0012 |
| 6 | VINORELBINE | 8 | 0.0011 |
| 7 | AMLODIPINE AND ATORVASTATIN | 3 | 0.0007 |
| 8 | POTASSIUM IODIDE | 1 | 0.0007 |
| 9 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selectin Blocker [EPC] | 2 | 0.0014 |
| 1 | CD30-directed Immunoconjugate [EPC] | 4 | 0.0004 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 24 | 0.0002 |
| 3 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 30 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Microtubule Inhibitor [EPC] | 26 | 0.0002 |
| 7 | Platinum-based Drug [EPC] | 42 | 0.0002 |
| 8 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |